BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 15661024)

  • 21. Drug evaluation: ADA-transduced hematopoietic stem cell therapy for ADA-SCID.
    Taupin P
    IDrugs; 2006 Jun; 9(6):423-30. PubMed ID: 16752313
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gene therapy for human SCID: dreams become reality.
    Buckley RH
    Nat Med; 2000 Jun; 6(6):623-4. PubMed ID: 10835669
    [No Abstract]   [Full Text] [Related]  

  • 23. Intrinsic defects of B cell function in X-linked severe combined immunodeficiency.
    White H; Thrasher A; Veys P; Kinnon C; Gaspar HB
    Eur J Immunol; 2000 Mar; 30(3):732-7. PubMed ID: 10741387
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Severe combined immunodeficiencies and related disorders.
    Fischer A; Notarangelo LD; Neven B; Cavazzana M; Puck JM
    Nat Rev Dis Primers; 2015 Oct; 1():15061. PubMed ID: 27189259
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neurocognitive function of patients with severe combined immunodeficiency.
    Shah AJ; Kohn DB
    Immunol Allergy Clin North Am; 2010 Feb; 30(1):143-51. PubMed ID: 20113891
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Haematopoietic stem cell transplantation for SCID patients: where do we stand?
    Cavazzana-Calvo M; André-Schmutz I; Fischer A
    Br J Haematol; 2013 Jan; 160(2):146-52. PubMed ID: 23167301
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Advances in hematopoietic stem cell transplantation for primary immunodeficiency.
    Gennery AR; Cant AJ
    Immunol Allergy Clin North Am; 2008 May; 28(2):439-56, x-xi. PubMed ID: 18424341
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Induced pluripotent stem cells and severe combined immunodeficiency: merely disease modeling or potentially a novel cure?
    Mikkers H; Pike-Overzet K; Staal FJ
    Pediatr Res; 2012 Apr; 71(4 Pt 2):427-32. PubMed ID: 22430378
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serial transplantations in nonobese diabetic/severe combined immunodeficiency mice of transduced human CD34+ cord blood cells: efficient oncoretroviral gene transfer and ex vivo expansion under serum-free conditions.
    Gammaitoni L; Lucchi S; Bruno S; Tesio M; Gunetti M; Pignochino Y; Migliardi G; Lazzari L; Aglietta M; Rebulla P; Piacibello W
    Stem Cells; 2006 May; 24(5):1201-12. PubMed ID: 16410386
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Hematopoietic stem cell transplantation in children with primary immunodeficiencies].
    Kelecić J; Rajić L; Tjesić-Drinković D
    Acta Med Croatica; 2009 Jun; 63(3):255-8. PubMed ID: 19827355
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Retroviral transduction of IL-7Ralpha into IL-7Ralpha-/- bone marrow progenitors: correction of lymphoid deficiency and induction of neutrophilia.
    Jiang Q; Li WQ; Aiello FB; Klarmann KD; Keller JR; Durum SK
    Gene Ther; 2005 Dec; 12(24):1761-8. PubMed ID: 16208423
    [TBL] [Abstract][Full Text] [Related]  

  • 32. From Severe Combined Immunodeficiency to Omenn syndrome after hematopoietic stem cell transplantation in a RAG1 deficient family.
    Martinez-Martinez L; Vazquez-Ortiz M; Gonzalez-Santesteban C; Martin-Nalda A; Vicente A; Plaza AM; Badell I; Alsina L; de la Calle-Martin O
    Pediatr Allergy Immunol; 2012 Nov; 23(7):660-6. PubMed ID: 22882342
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Of mice and men: the tale of two therapies.
    Hawley RG; Sobieski DA
    Stem Cells; 2002; 20(4):275-8. PubMed ID: 12110695
    [No Abstract]   [Full Text] [Related]  

  • 34. Unravelling the association of partial T-cell immunodeficiency and immune dysregulation.
    Liston A; Enders A; Siggs OM
    Nat Rev Immunol; 2008 Jul; 8(7):545-58. PubMed ID: 18551129
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A tale of two SCIDs.
    Shaw KL; Kohn DB
    Sci Transl Med; 2011 Aug; 3(97):97ps36. PubMed ID: 21865536
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Silencing p21(Waf1/Cip1/Sdi1) expression increases gene transduction efficiency in primitive human hematopoietic cells.
    Zhang J; Attar E; Cohen K; Crumpacker C; Scadden D
    Gene Ther; 2005 Oct; 12(19):1444-52. PubMed ID: 15877047
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gene therapy of primary immunodeficiencies.
    Fischer A; De Saint Basile G; Disanto JP; Hacein-Bey S; Sharara L; Cavazzana-Calvo M
    Adv Nephrol Necker Hosp; 1997; 26():107-20. PubMed ID: 8922128
    [No Abstract]   [Full Text] [Related]  

  • 38. Cytoreductive conditioning for severe combined immunodeficiency--help or hindrance?
    Laberko A; Gennery AR
    Expert Rev Clin Immunol; 2015; 11(7):785-8. PubMed ID: 26099343
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hematopoietic stem cell gene therapy: dead or alive?
    Ferguson C; Larochelle A; Dunbar CE
    Trends Biotechnol; 2005 Dec; 23(12):589-97. PubMed ID: 16216357
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chimerism in a child with severe combined immunodeficiency: a case report.
    Aureli A; Piancatelli D; Monaco PI; Ozzella G; Canossi A; Piazza A; Isacchi G; Caniglia M; Adorno D
    Pediatr Transplant; 2006 Sep; 10(6):744-6. PubMed ID: 16911501
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.